If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCINE.L Regulatory News (CINE)

  • There is currently no data for CINE

Response to media speculation

22 Aug 2022 07:00

RNS Number : 6936W
Cineworld Group plc
22 August 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM THE UNITED STATES OF AMERICA OR ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

22 August 2022

 

Cineworld Group plc ("Cineworld" or the "Group")

 

Response to media speculation

 

In response to media speculation, Cineworld is today providing an update to its announcement on 17 August 2022 regarding an evaluation of strategic options to both obtain additional liquidity and potentially restructure its balance sheet through a comprehensive deleveraging transaction.

 

Cineworld and Regal theaters globally are open for business as usual and continue to welcome guests and members. 

 

The strategic options through which Cineworld may achieve its restructuring objectives include a possible voluntary Chapter 11 filing in the United States and associated ancillary proceedings in other jurisdictions as part of an orderly implementation process. Cineworld is in discussions with many of its major stakeholders including its secured lenders and their legal and financial advisers.

 

Any such filing would be expected to allow the Group to access near-term liquidity and support the orderly implementation of a fully funded deleveraging transaction. Cineworld would expect to maintain its operations in the ordinary course until and following any filing and ultimately to continue its business over the longer term with no significant impact upon its employees. As previously announced, any deleveraging transaction would, however, result in very significant dilution of existing equity interests in Cineworld.

 

Cineworld's evaluation of these strategic options remains ongoing. A further announcement will be made if and when appropriate.

 

Contacts:

 

Cineworld Group plc:

Israel Greidinger

Nisan Cohen

Manuela Van Dessel

+44 (0)20 8987 5000

investors@cineworld.co.uk

FGS Global:

James Leviton

James Thompson

Ed Treadwell

+44 (0)20 7251 3801

cineworld-lon@fgsglobal.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
SPCPBMLTMTBTBBT
Date   Source Headline
31st Aug 202212:42 pmRNSStandard form for notification of major holdings
31st Aug 202211:37 amRNSResponse to press commentary
30th Aug 20222:30 pmRNSStandard form for notification of major holdings
26th Aug 20224:41 pmRNSSecond Price Monitoring Extn
26th Aug 20224:36 pmRNSPrice Monitoring Extension
25th Aug 20221:44 pmRNSStandard form for notification of major holdings
25th Aug 202210:00 amRNSStandard form for notification of major holdings
24th Aug 20224:40 pmRNSSecond Price Monitoring Extn
24th Aug 20224:35 pmRNSPrice Monitoring Extension
24th Aug 20224:15 pmRNSStandard form for notification of major holdings
24th Aug 202210:00 amRNSStandard form for notification of major holdings
22nd Aug 20222:00 pmRNSHolding(s) in Company
22nd Aug 20227:00 amRNSResponse to media speculation
17th Aug 20227:00 amRNSUpdate on trading, liquidity and capital structure
10th Jun 20225:15 pmRNSNotice of Interim Results
31st May 20229:00 amRNSTotal Voting Rights
24th May 20229:00 amRNSStandard form for notification of major holdings
20th May 20229:00 amRNSBlock Listing Application
12th May 20223:20 pmRNSResults of Annual General Meeting
10th May 20227:00 amRNSUpdate on Regal dissenting shareholders agreement
9th May 20229:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
4th May 20227:00 amRNSUpdate on Regal dissenting shareholders agreement
7th Apr 20224:00 pmRNSAnnual Report and Notice of Annual General Meeting
17th Mar 20227:00 amRNSPreliminary Results
25th Feb 20222:30 pmRNSStandard form for notification of major holdings
18th Feb 20227:04 amRNSUpdate on Regal Dissenting Shareholders Agreement
1st Feb 20227:00 amRNSUpdate on Regal dissenting shareholders agreement
28th Jan 20227:00 amRNSCineworld Group plc Cineplex Inc. Litigation
14th Jan 20224:30 pmRNSCommittee Changes
14th Jan 20227:00 amRNSCineworld Group plc Trading Update
15th Dec 20217:00 amRNSUpdate on Cineplex Inc. litigation
15th Nov 20217:00 amRNSTrading Update
9th Nov 20212:45 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Nov 20212:45 pmRNSStandard form for notification of major holdings
27th Sep 20212:45 pmRNSHolding(s) in Company
12th Aug 20217:00 amRNSInterim Results for the period ended 30 June 2021
30th Jul 20217:00 amRNSFurther Liquidity and Covenant Flexibility Secured
24th Jun 20216:00 pmRNSDirector Declaration
10th Jun 202110:54 amRNSDirector Declaration
24th May 20217:00 amRNSCompany Update
20th May 20212:00 pmRNSHolding(s) in Company
14th May 20216:31 pmRNSRegal Dissenting Shareholders Claim
12th May 20213:00 pmRNSResults of Annual General Meeting
10th May 20213:00 pmRNSBlock listing Interim Review
4th May 20212:00 pmRNSTotal Voting Rights
26th Apr 20212:00 pmRNSHolding(s) in Company
26th Apr 20218:00 amRNSBlock Listing Application
22nd Apr 20213:45 pmRNSHolding(s) in Company
15th Apr 20215:00 pmRNSDirector/PDMR Shareholding
13th Apr 20213:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.